A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Oclusión de la arteria central de la retina; Oclusión de rama de la arteria retiniana; OACR; ORAR
Las medidas empleadas para prevenir otras enfermedades de los vasos sanguíneos (vasculares), como la arteriopatía coronaria, pueden disminuir el riesgo de oclusión de las arterias retinianas. Estas medidas abarcan:
Algunas veces, se pueden emplear anticoagulantes para impedir que la arteria resulte bloqueada de nuevo. El ácido acetilsalicílico (aspirin) y otros anticoagulantes se utilizan si el problema está en las arterias carótidas. La warfarina y otros anticoagulantes más potentes se emplean si el problema está en el corazón.
Duker JS. Retinal arterial occlusion. In: Yanoff M, Duker JS, eds. Ophthalmology. 3rd ed. Maryland Heights, Mo: Mosby Elsevier;2008:chap 6.16.
Fay A. Diseases of the visual system. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 449.
Pokhrel PK, Loftus SA. Occular emergencies. Am Fam Physician. 2007;76:829-836.
Vortmann M, Schneider JI. Acute monocular visual loss. Emerg Med Clin North Am. 2008;26:73-96.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.800.492.5538